Full Press Release Details
WARREN, N.J.,Oct. 21, 2025/PRNewswire/ -- PTC Therapeutics, Inc. (NASDAQ:PTCT) announced today that the company will host a webcast conference call to report its third quarter 2025 financial results and provide an update on the company's business and outlook on Tuesday, November 4, at 4:30 p.m. ET.
To access the call by phone, pleaseclick hereto register, and you will be provided with dial-in details. To avoid delays, we recommend that participants dial in for the conference call 15 minutes before the start of the call. The webcast conference call can be accessed on the Investors section of the PTC website athttps://ir.ptcbio.com/events-presentations. A replay of the call will be available approximately two hours after completion of the call and will be archived on the company's website for 30 days.
ABOUT PTC THERAPEUTICS, INC.PTC is a global biopharmaceutical company dedicated to the discovery, development, and commercialization of clinically differentiated medicines for children and adults living with rare disorders. PTC is advancing a robust and diversified pipeline of transformative medicines as part of its mission to provide access to best-in-class treatments for patients with unmet medical needs. The company's strategy is to leverage its scientific expertise and global commercial infrastructure to optimize value for patients and other stakeholders. To learn more about PTC, please visitwww.ptcbio.comand follow on Facebook, X, and LinkedIn.
For more information, please contact:
Investors:Ellen Cavaleri+1 (615) 618-8228[email protected]
Media:Jeanine Clemente+1 (908) 912-9406[email protected]
SOURCE PTC Therapeutics, Inc.